tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Corbus Pharmaceuticals reports Q4 EPS ($2.61), consensus ($2.10)

As of December 31, 2022, the company has $59.2M of cash and investments on hand which is expected to fund operations through the second quarter of 2024, based on the current planned expenditures.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Read More on CRBP:

Disclaimer & DisclosureReport an Issue

1